Global Clostridial Diseases Market – Industry Trends and Forecast to 2029

Clostridial Diseases Market Analysis and Size

The global clostridial diseases market is expected to witness significant growth during the forecast period. increasing demand for clostridium vaccine among consumers and increased government awareness programmes for the benefit of vaccination among animals will boost the clostridial diseases market. COVID-19 also had a major impact on the market growth.

 Data Bridge Market Research analyses a growth rate in the global clostridial diseases market in the forecast period 2022-2029. The expected CAGR of global clostridial diseases market is tend to be around 12% in the mentioned forecast period. The market was valued at USD 2.22 billion in 2021, and it would grow upto USD 5.5 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Clostridial diseases are the infectious condition in animals and humans resulting from Clostridium species. It is a bacterial infection usually found in soil and organic materials. The disease caused in cattle through punctured wounds and contaminated food, which trigger the various factors and damage body tissues activating latent spores, followed by very rapid multiplication in the animal's body with toxin production, causing death within hours. But it can spread through animal to animals. The toxin may cause neuronal dysfunction and gastrointestinal tract damage.

Clostridial Diseases Market Scope and Segmentation

Global Clostridial Diseases Market Dynamics

Drivers

• Increase in Elderly Population

The global vitreoretinal disorders market is expected to witness a heavy growth rate in the forecast period driven by the factor of an aging population. The increasing demand in the global cataract market is a replication of the growing elderly population, as people aged over 60 years frequently develop conditions in which eyes have reduced elasticity, affecting the normal functioning. This boost the market growth.

• Increased Consumption of Antibiotics

Clostridial diseases are mostly linked to long-term antibiotic use. The rising consumption of antibiotics changes the colon bacteria, allowing Clostridium difficile bacteria to grow. Antibiotics such as clindamycin, quinolones and cephalosporins are more likely to cause the infections. The rising use of these antibiotics is definitely boosting the market growth.

Opportunities

• Increasing Demand for Retail Pharmacies

Opportunities for market expansion are created by the increase in the number of medicines for clostridial illnesses being distributed through retail pharmacies and the rise in the number of retail pharmacies in industrialised nations. Patients also favour retail pharmacies because they are convenient for acquiring medications.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global clostridial diseases market over a forecast period.

• High Cost

The huge expenditure associated with the treatment of vitreoretinal disorders surely hamper the market growth.

This global clostridial diseases market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global clostridial diseases market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Clostridial Diseases Market           

The Covid-19 pandemic greatly affected the market due to reduction in number of patient visits in hospitals and clinics for vitreoretinal disorders and interruption of numerous alternative procedures and outpatient visits. Although, the market is expected to recover with continuation of activities across various domains and approval and administration of Covid-19 vaccines.

Global Clostridial Diseases Market Scope

The global clostridial diseases market is segmented on the basis of disease type, animal species, exotoxins, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diseases Type

• Black Disease
• Blackleg
• Malignant Oedema
• Tetanus
• Botulism
• Others

Animal Species

• Cattle
• Sheep
• Poultry
• Horses
• Others

Exotoxins

• Enterotoxins
• Neurotoxins
• Others

Treatment

• Tetanus toxoid
• Multivalent Vaccine
• Antibiotics
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Clostridial Diseases Market Regional Analysis/Insights

The global clostridial diseases market is analysed and market size insights and trends are provided by disease type, animal species, exotoxins, distribution channel and end-user as referenced above.

The major countries covered in the global clostridial diseases market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global clostridial diseases market throughout the forecasted period due to increased incidence of clostridial diseases, generating the vaccination demand.

North America dominates the market due to the increased awareness about vaccination among the animal owners.

The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the market's current and future trends. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Clostridial Diseases Market Share Analysis

The global clostridial diseases market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global clostridial diseases market.

Key players operating in the global clostridial diseases market include:

• Boehringer Ingelheim International GmbH. (Germany)
• Zoetis (U.S.)
• Elanco (U.S.)
• Merck & Co. Inc. (U.S.)
• Phibro Animal Health Corporation (U.S.)
• Virbac (France)
• Vetoquinol (France)
• HIPRA (Spain)
• Ceva (France)
• Dechra (U.K.)
• Kyoritsuseiyaku Corporation (Japan)
• CHINA ANIMAL HUSBANDRY GROUP (China)
• Endovac Animal Health (U.S.)
• Zydus Group (India)
• Indian Immunologicals Pvt. Ltd. (India)
• UCBVET Saúde e Bem Estar Animal (US)
• American Reagent Inc. (U.S.)
• Neogen Corporation (US)
• Huvepharma (U.S.)

SKU-53889